TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
Record
Official procurement procedure

SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT)

Immunoglobulins
Purchase
CA
Published value
Not published
Submission deadline Not published
Lots published0
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Ministry of Defence: "SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT)". Published status: award. Published value: Value not published. Lot information not published. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityMinistry of DefenceScope & CategoriesNot publishedSubmission Window
Recorded
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Ministry of Defence
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Ministry of Defence. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1Bids / Report
100% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 1 active published awards; 1 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMinistry of Defence
Procedure methodNot published
Procurement categoryNot published
StatusNot published
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published3 May 2023, 12:45 BST
Last source update3 May 2023, 12:45 BST
Recurring procurementNot published
ClassificationImmunoglobulins, Purchase
Delivery area
CA
OCIDocds-h6vhtk-034881
What is being bought
The Chemical, Biological, Radiological and Nuclear (CBRN) team, part of Defence Equipment and Support (DE&S) organisation within the UK Ministry of Defence (MOD), has placed a contract with Emergent Biosolutions Canada Inc for the supply of Heptavalent Botulism Antitoxin (HBAT) for a period of 3 years. This is necessary to ensure maintenance of the capability with an acceptable stockholding level.
What changed
From the official release history
  1. Status changed to published status
    3 May 2023, 12:45 BST
  2. Official notice release published
    3 May 2023, 12:45 BST
  3. Buyer information updated
    3 May 2023, 12:45 BST
  4. Status changed to complete
    20 Jun 2022, 16:30 BST
  5. Official notice release published
    20 Jun 2022, 16:30 BST
  6. Buyer information updated
    20 Jun 2022, 16:30 BST
Lots and requirements (0)
Published by the contracting authority
No data
No lots are published for this procedure
Timeline
  1. Procedure published
    3 May 2023, 12:45 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 13 Apr 2023, 00:00 BST · £12,955,456
Commercial outcome and competition
Awards
Emergent BioSolutions Canada Inc.
Not published · Not published · active
Contracts
Contract
£12,955,456 · signed 13 Apr 2023, 00:00 BST · active
Bid statistics
bids: 1
electronicBids: 1
Buyer and organisations in this procedure

Ministry of Defence

Contracting authority GB-FTS-81776
View buyer profile

  • Ministry of Defence
    buyer

    Chemical Biological Radiological Nuclear (CBRN) Delivery Team, Yew 3A, #1342 MOD Abbey Wood, Bristol, BS34 8JH
    dale.lewis176@mod.gov.uk

  • Emergent BioSolutions Canada Inc.
    supplier

    155 Innovation Dr, Winnipeg, R3T 5Y3

  • Ministry of Defence
    reviewBody

    Bristol
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleIt is considered that this contract can be awarded using the negotiated procedure without prior publication of a contract notice, pursuant to Public Contracts Regulations 2015; where “Regulation 32 (2)(b)(ii) allows you to use the Negotiated procedure without Prior Publication when the exclusivity is due to technical reasons”. Summary of the Technical Reason: Emergent Biosolutions Canada Inc are currently the only licensed manufacturer for HBAT (BAT®) which provides antitoxin serotypes A-G for treatment of Botulism worldwide. This product is therefore the only product which provides the full capability to Defence.